Results 321 to 330 of about 288,185 (387)

Autophagy in PE: Dispute, Role and Potential Target

open access: yesCell Proliferation, EarlyView.
Autophagy homeostasis serves as a central hub regulating vascular remodelling during pregnancy. It integrates maternal, genetic, and fetal factors; shapes the functions of immune cells (NK cells, macrophages, and T cells); restrains endothelial inflammatory responses (cytokines, endothelial cell, oxidative/ER stress, and protein aggregation); and ...
Miao Xu   +12 more
wiley   +1 more source

Gestational diabetes mellitus in twin pregnancies versus singleton pregnancies—A retrospective case–control study

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims To compare markers of glycaemic regulation in twin and singleton pregnancies in women with gestational diabetes mellitus (GDM). Methods A retrospective case–control study was performed. 53 twin and 212 matched singleton pregnant women with gestational diabetes were included. Data were obtained from patient files.
Ninna L. Larsen   +5 more
wiley   +1 more source

Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Diabetic foot complications are a growing challenge for both individuals and society, underscoring the need for medical treatments and reliable risk markers. This study aimed to identify circulating metabolites associated with the prevalence and incidence of diabetic foot complications in individuals with type 1 diabetes (T1D).
Jonas A. Andersen   +10 more
wiley   +1 more source

Association between sodium‐glucose cotransporter 2 inhibitor use and clinical outcomes in patients with type 2 diabetes after urinary tract infection

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate whether initiating sodium‐glucose cotransporter 2 inhibitors (SGLT2i) within 3 months after a urinary tract infection (UTI) is associated with improved long‐term outcomes in patients with type 2 diabetes mellitus (T2DM), compared with dipeptidyl peptidase‐4 inhibitors (DPP‐4i).
Hsiao‐Wei Wang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy